BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 17878744)

  • 1. Acute administration of alprazolam, alcohol and their combination on cognitive performance and mood: A randomised, double-blind, placebo-controlled study.
    Aitken B; Hayley AC; Ford TC; Geier L; Shiferaw BA; Downey LA
    J Psychopharmacol; 2023 Dec; 37(12):1227-1237. PubMed ID: 37724443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination administration of alprazolam and N-Ethylmaleimide synergistically enhances sleep behaviors in mice with no potential CNS side effects.
    Zhu S; Shi J; Zhang Y; Chen X; Shi T; Li L
    PeerJ; 2024; 12():e17342. PubMed ID: 38737745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of alprazolam. Therapeutic implications.
    Greenblatt DJ; Wright CE
    Clin Pharmacokinet; 1993 Jun; 24(6):453-71. PubMed ID: 8513649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alprazolam kinetics following sublingual and oral administration.
    Scavone JM; Greenblatt DJ; Shader RI
    J Clin Psychopharmacol; 1987 Oct; 7(5):332-4. PubMed ID: 3680603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alprazolam-induced EEG spectral power changes in rhesus monkeys: a translational model for the evaluation of the behavioral effects of benzodiazepines.
    Berro LF; Overton JS; Reeves-Darby JA; Rowlett JK
    Psychopharmacology (Berl); 2021 May; 238(5):1373-1386. PubMed ID: 33594504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls.
    Pearlman EM; Wilbraham D; Dennehy EB; Berg PH; Tsai M; Doty EG; Kay GG
    Hum Psychopharmacol; 2020 Sep; 35(5):e2732. PubMed ID: 32449213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects.
    Liechti ME; Quednow BB; Liakoni E; Dornbierer D; von Rotz R; Gachet MS; Gertsch J; Seifritz E; Bosch OG
    Br J Clin Pharmacol; 2016 May; 81(5):980-8. PubMed ID: 26659543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-based meta-analysis of the effects of non-selective and α1-selective GABAA receptor agonists in healthy volunteers.
    Ren YP; Xie RJ; Marshall S; Li L; Zhou TY; Lu W
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1209-21. PubMed ID: 26257250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.
    Louizos C; Yáñez JA; Forrest ML; Davies NM
    J Pharm Pharm Sci; 2014; 17(1):34-91. PubMed ID: 24735761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of anti-conflict effects of zolpidem in rhesus monkeys following extended post-injection intervals.
    Rowlett JK; Kehne JH; Sprenger KJ; Maynard GD
    Psychopharmacology (Berl); 2011 Apr; 214(4):855-62. PubMed ID: 21103864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug effect on EEG connectivity assessed by linear and nonlinear couplings.
    Alonso JF; Mañanas MA; Romero S; Hoyer D; Riba J; Barbanoj MJ
    Hum Brain Mapp; 2010 Mar; 31(3):487-97. PubMed ID: 19894215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam.
    Snyder PJ; Werth J; Giordani B; Caveney AF; Feltner D; Maruff P
    Hum Psychopharmacol; 2005 Jun; 20(4):263-73. PubMed ID: 15912482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study.
    Riba J; Rodríguez-Fornells A; Urbano G; Morte A; Antonijoan R; Barbanoj MJ
    Psychopharmacology (Berl); 2001 Oct; 157(4):358-67. PubMed ID: 11605094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychomotor and electroencephalographic sequelae of cocaine dependence.
    Bauer LO
    NIDA Res Monogr; 1996; 163():66-93. PubMed ID: 8809854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different acute tolerance development to EEG, psychomotor performance and subjective assessment effects after two intermittent oral doses of alprazolam in healthy volunteers.
    Barbanoj MJ; Urbano G; Antonijoan R; Ballester MR; Valle M
    Neuropsychobiology; 2007; 55(3-4):203-12. PubMed ID: 17878744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences.
    Greenblatt DJ; Wright CE; von Moltke LL; Harmatz JS; Ehrenberg BL; Harrel LM; Corbett K; Counihan M; Tobias S; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):237-47. PubMed ID: 9757147
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.